Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease-Reference-Cited by-同舟云学术

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

Published:2017-05-17 Issue:5 Volume:12 Page:e0175674
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Caspell-Garcia Chelsea,Simuni Tanya,Tosun-Turgut Duygu,Wu I-Wei,Zhang Yu,Nalls Mike,Singleton Andrew,Shaw Leslie A.,Kang Ju-Hee,Trojanowski John Q.,Siderowf Andrew,Coffey Christopher,Lasch Shirley,Aarsland Dag,Burn David,Chahine Lana M.,Espay Alberto J.,Foster Eric D.,Hawkins Keith A.,Litvan Irene,Richard Irene,Weintraub Daniel,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Mild cognitive impairment in Parkinson's disease: A multicenter pooled analysis;D Aarsland;Neurology,2010

2. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study;D Aarsland;Archives of Neurology,2003

3. Longitudinal study of normal cognition in Parkinson disease;K Pigott;Neurology,2015

4. Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study;D Aarsland;Neurology,2009

5. Parkinson's disease: the quintessential neuropsychiatric disorder;D Weintraub;Movement Disorders,2011

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning for predicting cognitive decline within five years in Parkinson’s disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkers;PLOS ONE;2024-07-17

2. Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions;Nature Communications;2024-07-05

3. The role of ADAR editing and nonsense-mediated decay in Parkinson’s Disease;2024-05-21

4. Structural connectivity from DTI to predict mild cognitive impairment in de novo Parkinson’s disease;NeuroImage: Clinical;2024

5. Cognitive Profile in Parkinson’s Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta;Dementia and Geriatric Cognitive Disorders Extra;2023-10-26